老年人急性髓性白血病的治疗方法
Aseel Alsouqi1, Emily Geramita1, Annie Im1
1Hillman Cancer Center, Division of Hematology and Oncology, University of Pittsburgh Medical Center, Pittsburgh, PA 15232, USA.
患有急性髓性白血病 (AML) 的老年人面临着糟糕的结果. 本综述涵盖当前和新兴疗法,重点关注这一患者群体面临的挑战和临床试验代表性.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 老年病的医生 老年病的医生
背景情况:
- 急性髓性白血病 (AML) 是一种侵袭性癌症,主要影响老年人.
- 老年患者经常有并发症和不良表现状态,使治疗复杂化,尽管有新疗法,但导致结果不佳.
- 与疾病相关的因素,如突变特征,也会导致老年AML患者的耐治疗性.
研究的目的:
- 对患有急性髓性白血病 (AML) 的老年患者的治疗选择进行审查.
- 提供历史视角,并讨论目前正在临床试验中的新兴疗法.
- 突出管理老年AML患者的挑战,并将其纳入研究.
主要方法:
- 对老年人AML的既定和正在研究的治疗方法的文献综述.
- 分析标准的护理选择,包括venetoclax组合和向治疗.
- 讨论与患者相关的因素和临床试验参与.
主要成果:
- 标准治疗包括venetoclax加上低甲基化剂.
- 像FLT3和IDH抑制剂这样的向疗法显示出有前途.
- 老年患者面临重大挑战,他们在临床试验中的代表性仍然有限.
结论:
- 优化老年AML患者的治疗需要解决疾病和患者特异性因素.
- 针对性治疗和组合治疗的进步为人们提供了新的希望.
- 增加对临床试验多样性的关注对于改善这一群体的结果至关重要.
更多相关视频
09:57Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
Published on: March 5, 2018
09:01Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
Published on: March 26, 2018
相关概念视频
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Differentiation of Common Myeloid Progenitor Cells
Alzheimer's Disease: Treatment
Targeted Cancer Therapies
There are several types of targeted therapies against...
